115 related articles for article (PubMed ID: 23481457)
1. A new syringe adaptor for intravitreal injection of premature eye.
Kimura S; Tsukamoto M; Shiode Y; Hosogi M; Morizane Y
Retina; 2013 Apr; 33(4):889-90. PubMed ID: 23481457
[No Abstract] [Full Text] [Related]
2. REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY: A Multicenter Study.
Cernichiaro-Espinosa LA; Harper CA; Read SP; Wright LM; Scribbick FW; Young R; Negron CI; Rodríguez A; Berrocal AM
Retina; 2018 Jun; 38(6):1251-1255. PubMed ID: 29689029
[No Abstract] [Full Text] [Related]
3. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
Spandau U
Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
[No Abstract] [Full Text] [Related]
4. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
Tseng CC; Chen SN; Hwang JF; Lin CJ
J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
Flavahan PW; Lavy TE; Wykes W
Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
[TBL] [Abstract][Full Text] [Related]
7. Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose?
Connor AJ; Shafiq A
Eye (Lond); 2016 Nov; 30(11):1401-1403. PubMed ID: 27472209
[No Abstract] [Full Text] [Related]
8. Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity.
de Klerk TA; Park DY; Biswas S
Eye (Lond); 2013 Oct; 27(10):1218. PubMed ID: 23846376
[No Abstract] [Full Text] [Related]
9. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
Erol N; Gürsoy H; Sahin A; Basmak H
J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
[TBL] [Abstract][Full Text] [Related]
10. Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?
Azad R; Dave V; Jalali S
Indian J Ophthalmol; 2011; 59(6):421-2. PubMed ID: 22011483
[No Abstract] [Full Text] [Related]
11. Technique for Infant Intravitreal Injection in Treatment of Retinopathy of Prematurity.
Wright LM; Vrcek IM; Scribbick FW; Chang EY; Harper CA
Retina; 2017 Nov; 37(11):2188-2190. PubMed ID: 28196051
[No Abstract] [Full Text] [Related]
12. Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents.
Moisseiev E; Rudell J; Tieu EV; Yiu G
Curr Eye Res; 2017 Jul; 42(7):1059-1063. PubMed ID: 28306392
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.
Mireskandari K; Collins ME; Tehrani N
Can J Ophthalmol; 2015 Dec; 50(6):409-12. PubMed ID: 26651298
[No Abstract] [Full Text] [Related]
14. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
[TBL] [Abstract][Full Text] [Related]
15. How Does the Standard of Care Evolve? Anti-Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example.
Chiang MF
Ophthalmology; 2018 Oct; 125(10):1485-1487. PubMed ID: 30243329
[No Abstract] [Full Text] [Related]
16. Retrolental Hemorrhage in Berger's Space After Intravitreal Bevacizumab Injection for Retinopathy of Prematurity.
Shah PR; Sachan A; Chandra P
J Pediatr Ophthalmol Strabismus; 2020 Oct; 57():e71-e73. PubMed ID: 33090229
[TBL] [Abstract][Full Text] [Related]
17. [Alarming use of anti-VEGF therapy in premature infants].
Hård AL; Hellström A
Lakartidningen; 2011 Dec 7-13; 108(49):2600. PubMed ID: 22468401
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
[TBL] [Abstract][Full Text] [Related]
19. [VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM; Helbig H
Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
[TBL] [Abstract][Full Text] [Related]
20. Dramatic regression of persistent tunica vasculosa lentis associated with retinopathy of prematurity following treatment with intravitreal bevacizumab.
Goldman DR; Baumal CR
J Pediatr Ophthalmol Strabismus; 2013 Jun; 50 Online():e27-9. PubMed ID: 24601434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
